FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda has given "Apply" recommendation to Dr Lal PathLabs IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 1 | 0 | 0 | 0 | 0 |
% | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | Apply |
[Dilip Davda]
As this is the first company under consumer healthcare diagnosis services sector having established brand and has no listed peers to compare with, it may enjoy the benefit of first mover of the sector and hence may attract fancy of investors. Although it being an expensive offer, moderate investment for short to medium term may be considered.
Read detail review...Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|